Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06836141 · ClinicalTrials.gov registry record
Biomarkers for Cognitive Decline in Intracerebral Hemorrhage
A clinical trial of Primary Intracerebral Hemorrhage, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- 118
- Enrollment target
- 1
- Study location
NCT06836141 is a study of Primary Intracerebral Hemorrhage that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 118 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06836141, a study of Primary Intracerebral Hemorrhage, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to see if silent brain infarcts (SBIs), or stroke-like symptoms detectable during brain imaging, are a possible contributor to cognitive decline for patients diagnosed with spontaneous intracerebral hemorrhage (sICH), or blood clot in the brain. The main questions it aims to answer are * if SBIs in sICH are associated with a lower cognitive level and more rapid cognitive decline * if SBIs in sICH are associated with certain findings on brain imaging * if SBIs in sICH are associated with higher inflammation measured by certain blood tests Participants will undergo * cognitive testing during hospitalization, and at 3, 6 and 12 months after the sICH * Magnetic Resonance Imaging (MRI) of the brain during hospitalization and 12 months after the sICH * blood draws during hospitalization and at 3, 6 and 12 months after the sICH
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood Draw
- DIAGNOSTIC_TEST MRI
- DIAGNOSTIC_TEST Cognitive Test
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-08-02 |
| Est. Completion | 2029-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06836141
The ClinicalTrials.gov registry entry for NCT06836141 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Intracerebral Hemorrhage appearing as the primary indexed condition, and to 3 interventions - of which Blood Draw is the first listed.
NCT06836141 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06836141 about?
NCT06836141 is a clinical study titled "Biomarkers for Cognitive Decline in Intracerebral Hemorrhage". The goal of this clinical trial is to see if silent brain infarcts (SBIs), or stroke-like symptoms detectable during brain imaging, are a possible contributor to cognitive decline for patients diagnosed with spontaneous intracerebral hemorrhage (sICH), or blood clot in the brain. The main questions ...
What is the current status of trial NCT06836141?
This trial is currently recruiting. The enrollment target is 118 participants. The study started on 2025-08-02. Estimated completion is 2029-08-01.
What conditions does trial NCT06836141 study?
This clinical trial studies the following conditions: Primary Intracerebral Hemorrhage.
What interventions are being tested in trial NCT06836141?
The interventions under investigation include: Blood Draw (DIAGNOSTIC_TEST), MRI (DIAGNOSTIC_TEST), Cognitive Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06836141?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06836141 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.